PGR and breast cancer: We note that the expression of classical markers of breast cancer subtypes in our analysis of the TCGA data set (with the exception of PgR and HER2) does not at first glance correspond to commonly presented enrichments since these relative levels are presented in the context of comparison with matched, normal tissue rather than over a broad range of cancer subtypes.